Experimental studies demonstrated that angiotensin II infusion in apolipoprotein E/adiponectin double-knockout (Apoe−/− Apn−/−) mice led to an increased incidence of AAA as compared to Apoe−/− mice. This evidence concerns the gene ADIPOQ and triple-A syndrome.